论文信息 - 70 A Randomized, Double-Blind, Placebo-Controlled Phase II Study (MOT114479) to Evaluate the Safety and Efficacy and Dose Response of 28 Days of Orally Administered Camicinal, a Motilin Receptor Agonist, in Diabetics With Gastroparesis - 字舞流文

70 A Randomized, Double-Blind, Placebo-Controlled Phase II Study (MOT114479) to Evaluate the Safety and Efficacy and Dose Response of 28 Days of Orally Administered Camicinal, a Motilin Receptor Agonist, in Diabetics With Gastroparesis

Braden Kuo | Henry P. Parkman | Jan Tack | A. Hobson | B. Kuo | H. Parkman | J. Tack | P. Hellström | G. Dukes | M. Barton | R. Dobbins | Tal Otiker | Lakshmi Vasist Johnson | D. Robertson | Matthew E. Barton | Anthony Hobson | Per M. Hellström | Tal Otiker | Darren C. Robertson | Robert L. Dobbins | George E. Dukes | T. Otiker